fda drug shortage list semaglutide status january 2025 FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize GLP-1 No Longer on FDA's

Jenni Hecht , Sturgis, Michigan resident and plasma seller

Several factors increase your likelihood significantly: History of GERD or acid reflux , even if it was well-controlled before starting tirzepatide Hiatal hernia , which already weakens the lower esophageal sphincter Obesity , which increases abdominal pressure (though this improves as you lose weight on the medication) Smoking , which relaxes the esophageal sphincter Certain medications like NSAIDs, calcium channel blockers, or bisphosphonates that independently increase reflux risk Eating large meals or eating close to bedtime If you had occasional heartburn before starting tirzepatide, the medication can amplify it significantly during the early weeks

Many of the medical evaluations and follow-ups are covered by insurance

doi: 10.1007/s44337-025-00428-0 52